ClinVar Miner

Submissions for variant NM_004380.3(CREBBP):c.283G>A (p.Val95Met)

dbSNP: rs756802946
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000989513 SCV001139926 uncertain significance Rubinstein-Taybi syndrome due to CREBBP mutations 2019-05-28 criteria provided, single submitter clinical testing
UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill RCV000989513 SCV001423841 uncertain significance Rubinstein-Taybi syndrome due to CREBBP mutations criteria provided, single submitter research CREBBP c.283G>A, [p.V95M] has not been reported previously in the medical literature, and is a variant of uncertain significance.
GeneDx RCV001655658 SCV001871280 likely benign not provided 2021-07-15 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 8616895, 27535533, 29259186)
Invitae RCV002550613 SCV003452853 likely benign Rubinstein-Taybi syndrome 2023-04-05 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001655658 SCV004033453 uncertain significance not provided 2024-01-01 criteria provided, single submitter clinical testing CREBBP: PP2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.